Passage BIO, Inc. (PASG) stock
PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.22+0.09 (+2.18%)
Close on Nov 17, 2026Market cap $13.58MP/E –Yield –
Passage BIO market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Passage BIO's market cap was $12.87M on Nov 11, 2026, against $28.07M a year earlier. Over the last 5 years it ranged from $11.10M to $351.80M, with a median of $44.37M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.87M | -65.7% |
| 2025 | Dec 31, 2025 | $37.51M | +4.4% |
| 2024 | Dec 31, 2024 | $35.93M | -36.7% |
| 2023 | Dec 29, 2023 | $56.78M | -26.5% |
| 2022 | Dec 30, 2022 | $77.20M | -78.1% |
| 2021 | Dec 31, 2021 | $351.80M | -70.5% |
| 2020 | Dec 31, 2020 | $1.19B | – |
See a number that looks wrong?